Transdermal estrogen
Transdermal estrogen is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Estradiol Supplementation and Rotator Cuff Repair
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
Estrogen Supplementation and Bone Health in Women With CF
Transdermal Estrogen in Women With Anorexia Nervosa
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
Clinical Trials (6)
Estradiol Supplementation and Rotator Cuff Repair
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
Estrogen Supplementation and Bone Health in Women With CF
Transdermal Estrogen in Women With Anorexia Nervosa
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6